{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06250205",
            "orgStudyIdInfo": {
                "id": "TA-8995-13"
            },
            "organization": {
                "fullName": "NewAmsterdam Pharma",
                "class": "INDUSTRY"
            },
            "briefTitle": "Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib",
            "officialTitle": "A Study to Evaluate the Effect of Daily Doses of Obicetrapib Tablets on the Pharmacokinetics of Drospirenone and Ethinyl Estradiol in Healthy Adult Female Subjects",
            "therapeuticArea": [
                "Other"
            ],
            "study": "evaluate-the-pharmacokinetics-of-a-combined-oral-contraceptive-coc-with-and-without-obicetrapib"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-05",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-07-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-01",
            "studyFirstSubmitQcDate": "2024-02-01",
            "studyFirstPostDateStruct": {
                "date": "2024-02-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-13",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "NewAmsterdam Pharma",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Novum",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A study to evaluate the impact of Obicetrapib on the PK levels of Drospirenone and Ethinyl Estradiol (COC) in 30 adult female, healthy volunteers.",
            "detailedDescription": "This is an interventional, drug-drug interaction study to evaluate the effect of daily doses of Obicetrapib tablets on the pharmacokinetics of a combined oral contraceptive (COC), Drospirenone and Ethinyl Estradiol."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy Volunteers"
            ],
            "keywords": [
                "DDI, drug-drug interaction, combined oral contraceptive"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "Open-label, multiple-dose, fixed sequence, drug-drug interaction study.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment B+C: Obicetrapib + Drospirenone/Ethinyl Estradiol (COC)",
                    "type": "EXPERIMENTAL",
                    "description": "Obicetrapib 10 mg tablets and Drospirenone (3mg)/Ethinyl Estradiol (0.02mg) tablet",
                    "interventionNames": [
                        "Drug: Obicetrapib",
                        "Drug: Obicetrapib + Drospirenone / Ethinyl Estradiol (COC)"
                    ]
                },
                {
                    "label": "Treatment B: Obicetrapib",
                    "type": "EXPERIMENTAL",
                    "description": "Obicetrapib 10 mg tablets (daily)",
                    "interventionNames": [
                        "Drug: Obicetrapib"
                    ]
                },
                {
                    "label": "Treatment C: Drospirenone/Ethinyl Estradiol tablets (COC)",
                    "type": "EXPERIMENTAL",
                    "description": "Drospirenone (3mg)/Ethinyl Estradiol tablets (0.02mg) tablet",
                    "interventionNames": [
                        "Drug: Drospirenone / Ethinyl Estradiol (COC)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Obicetrapib",
                    "description": "oral administration",
                    "armGroupLabels": [
                        "Treatment B+C: Obicetrapib + Drospirenone/Ethinyl Estradiol (COC)",
                        "Treatment B: Obicetrapib"
                    ],
                    "otherNames": [
                        "10 mg tablet"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Obicetrapib + Drospirenone / Ethinyl Estradiol (COC)",
                    "description": "oral administration",
                    "armGroupLabels": [
                        "Treatment B+C: Obicetrapib + Drospirenone/Ethinyl Estradiol (COC)"
                    ],
                    "otherNames": [
                        "tablets"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Drospirenone / Ethinyl Estradiol (COC)",
                    "description": "oral administration",
                    "armGroupLabels": [
                        "Treatment C: Drospirenone/Ethinyl Estradiol tablets (COC)"
                    ],
                    "otherNames": [
                        "tablets"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Maximum observed plasma concentration (Cmax) of COC",
                    "description": "Plasma Cmax concentration of COC with and without Obicetrapib",
                    "timeFrame": "Upon completion of Treatment C (Day -6) and Treatments B+C (Day 12)"
                },
                {
                    "measure": "Area under the plasma concentration-time (AUC0-\u03c4) curve for COC with and without coadministration with Obicetrapib",
                    "description": "Plasma AUC0-\u03c4 for COC with and without coadministration of Obicetrapib",
                    "timeFrame": "Upon completion of Treatment C (Day -6) and Treatments B+C (Day 12)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Non-pregnant, non-lactating, non-tobacco-, non-nicotine-using female, 18-35 years of age, inclusive, who is a candidate for hormonal contraception (as determined by the Investigator).\n* Subject has a BMI of 18.5-29.9 kg/m\u00b2, inclusive. BMI will be calculated using Novum Pharmaceutical Research Services Standard Operating Procedures.\n* If the subject is currently using a hormonal method of contraception, the subject is willing and agrees to stop using her hormonal contraceptive throughout the duration of the study and is prepared to abstain from sexual intercourse or use a reliable non-hormonal method of contraception, as outlined below\n\nExclusion Criteria:\n\n* Male\n* Have given birth or been pregnant within 3 months before initial dosing, or is currently pregnant, lactating or likely to become pregnant during the study.\n* History of Hypertension, or seated blood pressure for a minimum of 5 minutes \\>140mmHg systolic, or \\> 80 mmHg, diastolic at screening",
            "healthyVolunteers": true,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "maximumAge": "35 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Linda Angeline",
                    "role": "CONTACT",
                    "phone": "702 435 3739",
                    "phoneExt": "423",
                    "email": "LAngeline@novumprs.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kent A Swaine",
                    "affiliation": "Novum Pharmaceutical Research Services, Inc.",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "NOVUM",
                    "status": "RECRUITING",
                    "city": "Las Vegas",
                    "state": "Nevada",
                    "zip": "89121",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.17497,
                        "lon": -115.13722
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000035144",
                    "term": "Drospirenone"
                },
                {
                    "id": "C000007630",
                    "term": "Estradiol 17 beta-cypionate"
                },
                {
                    "id": "C000074283",
                    "term": "Estradiol 3-benzoate"
                },
                {
                    "id": "D000004997",
                    "term": "Ethinyl Estradiol"
                },
                {
                    "id": "C000534342",
                    "term": "Drospirenone and ethinyl estradiol combination"
                },
                {
                    "id": "D000004958",
                    "term": "Estradiol"
                },
                {
                    "id": "C000008958",
                    "term": "Polyestradiol phosphate"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004967",
                    "term": "Estrogens"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000080066",
                    "term": "Contraceptive Agents, Hormonal"
                },
                {
                    "id": "D000003270",
                    "term": "Contraceptive Agents"
                },
                {
                    "id": "D000012102",
                    "term": "Reproductive Control Agents"
                },
                {
                    "id": "D000003271",
                    "term": "Contraceptive Agents, Female"
                },
                {
                    "id": "D000003278",
                    "term": "Contraceptives, Oral, Hormonal"
                },
                {
                    "id": "D000003276",
                    "term": "Contraceptives, Oral"
                },
                {
                    "id": "D000000451",
                    "term": "Mineralocorticoid Receptor Antagonists"
                },
                {
                    "id": "D000006727",
                    "term": "Hormone Antagonists"
                },
                {
                    "id": "D000062865",
                    "term": "Diuretics, Potassium Sparing"
                },
                {
                    "id": "D000004232",
                    "term": "Diuretics"
                },
                {
                    "id": "D000045283",
                    "term": "Natriuretic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8145",
                    "name": "Ethinyl Estradiol",
                    "asFound": "Protection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6494",
                    "name": "Contraceptive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M6500",
                    "name": "Contraceptives, Oral",
                    "relevance": "LOW"
                },
                {
                    "id": "M6501",
                    "name": "Contraceptives, Oral, Combined",
                    "relevance": "LOW"
                },
                {
                    "id": "M266279",
                    "name": "Estradiol 17 beta-cypionate",
                    "asFound": "Cell lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M266280",
                    "name": "Estradiol 3-benzoate",
                    "asFound": "Cell lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8108",
                    "name": "Estradiol",
                    "asFound": "Cell lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M234941",
                    "name": "Polyestradiol phosphate",
                    "asFound": "Cell lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M208589",
                    "name": "Drospirenone",
                    "asFound": "Maturation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M185407",
                    "name": "Drospirenone and ethinyl estradiol combination",
                    "asFound": "Rapid Sequence Intubation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8116",
                    "name": "Estrogens",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M2116",
                    "name": "Contraceptive Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M6495",
                    "name": "Contraceptive Agents, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M6502",
                    "name": "Contraceptives, Oral, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M3797",
                    "name": "Mineralocorticoid Receptor Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M11871",
                    "name": "Mineralocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M7411",
                    "name": "Diuretics",
                    "relevance": "LOW"
                },
                {
                    "id": "M30025",
                    "name": "Diuretics, Potassium Sparing",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "NaAg",
                    "name": "Natriuretic Agents"
                }
            ]
        }
    },
    "hasResults": false
}